Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q4DT
|
||||
Former ID |
DIB009275
|
||||
Drug Name |
HuMax-TAC
|
||||
Synonyms |
Anti-IL-2R antibody, Genmab/Merck Serono
|
||||
Drug Type |
Antibody
|
||||
Indication | Autoimmune diabetes [ICD10:E08-E13] | Terminated | [547655] | ||
Company |
Genmab A/S
|
||||
Target and Pathway | |||||
Target(s) | Interleukin-2 receptor alpha chain | Target Info | [525375] | ||
PANTHER Pathway | Interleukin signaling pathway | ||||
Pathway Interaction Database | IL12-mediated signaling events | ||||
Calcineurin-regulated NFAT-dependent transcription in lymphocytes | |||||
Arf6 trafficking events | |||||
SHP2 signaling | |||||
IL2-mediated signaling events | |||||
IL2 signaling events mediated by PI3K | |||||
IL2 signaling events mediated by STAT5 | |||||
Calcium signaling in the CD4+ TCR pathway | |||||
Downstream signaling in naï | |||||
IL12 signaling mediated by STAT4 | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.